Observational studyMedicine2015

The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China.

Yu Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.